Shares of Merrimack Pharmaceuticals fell 5.41% to $6.63 at 11:19 EST on Tuesday, after four consecutive sessions in a row of losses. NASDAQ Composite is sliding 2.02% to $13,614.97, after two successive sessions in a row of losses. This seems, up to now, an all-around rough trend trading session today.

Merrimack Pharmaceuticals’s last close was $7.01, 42.53% below its 52-week high of $9.45.

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $6.63 at 11:19 EST, way under its 52-week high of $9.45 and way above its 52-week low of $2.97.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s value is below its 50-day moving average of $6.88 and way above its 200-day moving average of $5.87.

More news about Merrimack Pharmaceuticals.


Please enter your comment!
Please enter your name here